Categories: All postsAnalysts

Calian Group upgraded to “Buy” at Echelon Wealth

A fourth quarter that was better than expected has Echelon Wealth Partners analyst Ralph Garcea upgrading Calian Group (Calian Group Stock Quote, Chart, News: TSX:CGY).

On Wednesday, Calian Group reported its fourth quarter and fiscal 2017 results. In the fourth quarter, the company earned $4.3-million on revenue of $72.3-million, a topline that was up five per cent over the same period last year.

“Once again, the team has delivered solid results for our shareholders,” said CEO Kevin Ford. “I am extremely proud of their efforts in the quarter and full-year results. We continue to see progress across all elements of our four-pillar growth strategy. Equally, I am very proud of our continued high customer satisfaction metrics across all of our services again this year — the Calian team is passionate about ensuring we are adding value to our customers objectives.”

Garcea notes that the quarter beat his and the street consensus for EBITDA, earnings, and revenue. The company’s gross margin figure of 19.6 per cent also topped his 18.0 per cent estimate. The analyst broke down the quarter.

“The mix of revenues in the quarter helped the margin beat on gross margin and EBITDA, especially in the Systems Engineering Division (SED) where higher labour components were delivered,” Garcea explains. “CFOPS excluding working capital was $6.7M (EWP: $4.2M) with FCF of ($1.2M) or ($0.15)/sh. CGY signed $932M worth of contracts in the quarter and book-to-bill came in at 12.9x. Backlog as at quarter end was $1,261M, up from $401M q/q. CGY upped its credit facility last quarter from $10M to $40M to facilitate organic and inorganic growth with comfort levering up to 1x EBITDA. F2018 guidance was provided with revenue expected between $290-310M and EPS between $1.90-2.20. Guidance was higher than our expectations of $280M, thus we are reflecting management’s expectations into our new estimates and anticipate continued execution.”

In a research update to clients today, Garcea upgraded Calian Group from “Hold” to “Buy” and raised his one-year price target on the stock from $30.00 to $40.00, implying a return of 21 per cent at the time of publication.

Garcea thinks Calian Group will generate EBITDA of $25.0-million on revenue of $301.0-million in fiscal 2018. He expects those numbers will improve to EBITDA of $27.0-million on a topline of $314.0-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

4 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

10 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

11 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

12 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

1 day ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

1 day ago